Nanohale AG (ETR:FYB) | Finanzwire

Basculer en Français

9477	Companies
185475	Keywords
117817	Articles
99317	Press releases

Home
Companies
Nanohale AG

BRIEF

published on 07/10/2025 at 06:35, 4 months 26 days ago

Formycon Completes Patient Enrollment for Keytruda® Biosimilar FYB206

Formycon FYB206 Keytruda® Biosimilar Development Dahlia Study
PRESS RELEASE

published on 07/10/2025 at 06:30, 4 months 26 days ago

Formycon successfully completes patient enrollment for the clinical development of its Keytruda® biosimilar candidate FYB206
Formycon completes patient enrollment for clinical development of Keytruda biosimilar FYB206. Results expected in Q1 2026. Streamlined program accelerates development

Clinical Development Biosimilar Formycon Keytruda Patient Enrollment
BRIEF

published on 07/01/2025 at 13:20, 5 months 4 days ago

Bio Usawa to Commercialize FYB201 in Sub-Saharan Africa

Formycon AG FYB201 Sub-Saharan Africa Bio Usawa Diabetic Macular Edema
PRESS RELEASE

published on 07/01/2025 at 13:15, 5 months 4 days ago

Bio Usawa becomes partner for the commercialization of FYB201/ BioUcenta™ (ranibizumab) across Sub-Saharan Africa
Bio Usawa partners with Formycon AG for the commercialization of FYB201/BioUcenta™ (ranibizumab) in Sub-Saharan Africa, expanding access to ophthalmic treatment for diabetic complications

Formycon AG Commercialization FYB201 Bio Usawa BioUcenta
BRIEF

published on 06/27/2025 at 15:56, 5 months 7 days ago

Formycon Successfully Places EUR 70 Million Bond Amid High Demand

Biosimilars Investor Interest Capital Market EUR 70 Million Formycon Bond
PRESS RELEASE

published on 06/27/2025 at 15:51, 5 months 7 days ago

Formycon increases bond volume following oversubscription – Bond 2025/2029 with a volume of EUR 70 million successfully and entirely placed
Formycon AG successfully and entirely places EUR 70 million bond 2025/2029 following oversubscription, interest rate fixed at 7.00% p.a

Formycon AG Interest Rate Oversubscription EUR 70 Million Bond 2025/2029
BRIEF

published on 06/27/2025 at 15:50, 5 months 7 days ago

Formycon Secures EUR 70 Million Floating Rate Bond

Formycon AG Financial Issuance Biosimilar Development EUR 70 Million Bond Floating Rate Bond
PRESS RELEASE

published on 06/27/2025 at 15:45, 5 months 7 days ago

EQS-Adhoc: Formycon successfully places an EUR 70 million senior unsecured floating rate bond
Formycon AG successfully places EUR 70 million senior unsecured floating rate bond, issued with a maturity of 4 years, financed for biosimilar product portfolio development

Formycon AG Financial Market Senior Unsecured Bond Biosimilar Products EUR 70 Million
BRIEF

published on 06/26/2025 at 06:35, 5 months 9 days ago

Teva to Commercialize Formycon’s Biosimilar Fymskina® in Germany

Germany Biosimilar Formycon Teva Fymskina®
PRESS RELEASE

published on 06/26/2025 at 06:30, 5 months 9 days ago

Teva becomes secondary commercialization partner for Formycon's Stelara® biosimilar FYB202 (ustekinumab) under the brand name Fymskina® in Germany
Teva partners with Formycon for commercialization of Stelara biosimilar FYB202 (ustekinumab) as Fymskina in Germany. Market launch planned in Q3 2025

Biosimilar Formycon Teva Stelara Fymskina

Accesswire

Published on 12/05/2025 at 14:00, 51 minutes ago

Ocean Power Technologies Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 14:00, 51 minutes ago

Bonk, Inc. Highlights Major Ecosystem Milestone: Launch of Regulated BONK ETP on SIX Swiss Exchange
Published on 12/05/2025 at 02:35, 12 hours 16 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 12 hours 21 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 13 hours 51 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 14:22, 28 minutes ago

EQS-Adhoc: Jungheinrich AG: Jungheinrich expects to complete sale of its Russian subsidiary in 2026 and adjusts forecast for the 2025 financial year
Published on 12/05/2025 at 14:16, 34 minutes ago

Advanced Blockchain AG: Successful Completion of Token Generation Event of Portfolio company Talisman
Published on 12/05/2025 at 14:10, 40 minutes ago

The Kingdom of Saudi Arabia Launches a New Official Platform, "Saudi Properties", Ahead of the Non-Saudi Property Ownership Law
Published on 12/05/2025 at 13:45, 1 hour 5 minutes ago

BingX Introduces Recurring Buy to Help Users Ride Out Crypto Market Swings
Published on 12/05/2025 at 13:00, 1 hour 50 minutes ago

Zentra Group plc: Posting of Notice of Annual General Meeting

Les Echos

Published on 12/05/2025 at 08:45, 6 hours 6 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 20 hours 51 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 21 hours 6 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 21 hours 6 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 7 hours ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

View all LES ECHOS COMFI WIRE